Cargando…
Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes
Some of the largest improvements in clinical outcomes for patients with solid cancers observed over the past 3 decades have been from concurrent treatment with chemotherapy and radiotherapy (RT). The lethal effects of RT on cancer cells arise primarily from damage to DNA. Ruthenium (Ru) is a transit...
Autores principales: | Carter, R, Westhorpe, A, Romero, MJ, Habtemariam, A, Gallevo, CR, Bark, Y, Menezes, N, Sadler, PJ, Sharma, RA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751532/ https://www.ncbi.nlm.nih.gov/pubmed/26867983 http://dx.doi.org/10.1038/srep20596 |
Ejemplares similares
-
Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
por: Carter, Rebecca, et al.
Publicado: (2019) -
Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib
por: Znati, Sami, et al.
Publicado: (2020) -
Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone
Complexes: Solution Behavior and Antiproliferative Activity
por: Gatti, Anna, et al.
Publicado: (2018) -
Exploring pta Alternatives in the Development of Ruthenium–Arene Anticancer Compounds
por: Kljun, Jakob, et al.
Publicado: (2023) -
Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes
por: Hanif, Muhammad, et al.
Publicado: (2013)